Filing Details
- Accession Number:
- 0001127602-25-015457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-23 15:16:26
- Reporting Period:
- 2025-05-22
- Filing Date:
- 2025-05-23
- Accepted Time:
- 2025-05-23 15:16:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc. | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782135 | Johanna Mercier | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-22 | 12,500 | $66.64 | 136,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-22 | 12,500 | $107.52 | 124,152 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-05-22 | 12,500 | $66.64 | 136,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-22 | 12,500 | $107.52 | 124,152 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-22 | 3,000 | $107.52 | 121,152 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2025-05-22 | 12,500 | $0.00 | 12,500 | $66.64 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2025-05-22 | 12,500 | $0.00 | 12,500 | $66.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 135,610 | 2029-07-24 | No | 4 | M | Direct | |
| 123,110 | 2029-07-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- Sale prices reported for the transactions reported here range from $107.06 to $107.95. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $106.96 to $107.95. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $107.16 to $107.87. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Billionaire Hedge Funds
